These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 4053120

  • 1. 21-Deoxytetrahydroaldosterone excretion in primary hyperaldosteronism.
    Abdelhamid S, Lewicka S, Vecsei P, Winter J.
    Cardiology; 1985; 72 Suppl 1():102-6. PubMed ID: 4053120
    [Abstract] [Full Text] [Related]

  • 2. Radioimmunoassay of urinary 21-deoxytetrahydroaldosterone in primary aldosteronism and 21-hydroxylase deficiency.
    Lewicka S, Winter J, Bokkenheuser VD, Vecsei P, Abdelhamid S, Heinrich U.
    J Steroid Biochem; 1986 Feb; 24(2):581-6. PubMed ID: 3486323
    [Abstract] [Full Text] [Related]

  • 3. Urinary kallikrein excretion in patients with primary aldosteronism: differentiation of adrenal adenoma from idiopathic adrenal hyperplasia.
    Nakada T.
    Urol Int; 1984 Feb; 39(1):40-5. PubMed ID: 6375065
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fludrocortisone suppression test in normal subjects, in patients with essential hypertension and in patients with various forms of aldosteronism.
    Lund JO, Nielsen MD.
    Acta Endocrinol (Copenh); 1980 Jan; 93(1):100-7. PubMed ID: 6986736
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Urinary excretion of 19-noraldosterone, 18, 19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism.
    Takeda Y, Miyamori I, Iki K, Takeda R, Vecsei P.
    Acta Endocrinol (Copenh); 1992 Jun; 126(6):484-8. PubMed ID: 1642080
    [Abstract] [Full Text] [Related]

  • 10. Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study.
    Abdelhamid S, Blomer R, Hommel G, Haack D, Lewicka S, Fiegel P, Krumme B.
    Am J Hypertens; 2003 Jul; 16(7):522-30. PubMed ID: 12850384
    [Abstract] [Full Text] [Related]

  • 11. Aldosterone metabolites and possible aldosterone precursors in hypertension.
    Vecsei P, Abdelhamid S, Mittelstädt GV, Lichtwald K, Haack D, Lewicka S.
    J Steroid Biochem; 1983 Jul; 19(1A):345-51. PubMed ID: 6887870
    [Abstract] [Full Text] [Related]

  • 12. Comparison of 24-h urinary aldosterone level and random urinary aldosterone-to-creatinine ratio in the diagnosis of primary aldosteronism.
    Wu CH, Yang YW, Hu YH, Tsai YC, Kuo KL, Lin YH, Hung SC, Wu VC, Wu KD, Taiwan Primary Aldosteronism Investigation (TAIPAI) Study Group.
    PLoS One; 2013 Jul; 8(6):e67417. PubMed ID: 23840695
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of unconjugated 3 alpha,5 beta-tetrahydroaldosterone and 5 beta-dihydroaldosterone measured by radioimmunoassay.
    Lewicka S, Vecsei P.
    Clin Endocrinol (Oxf); 1985 Feb; 22(2):123-33. PubMed ID: 3987065
    [Abstract] [Full Text] [Related]

  • 14. Effects of glucocorticoid administration on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
    Newton MA, Laragh JH.
    J Clin Endocrinol Metab; 1968 Jul; 28(7):1014-22. PubMed ID: 4298943
    [No Abstract] [Full Text] [Related]

  • 15. Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
    Newton MA, Laragh JH.
    J Clin Endocrinol Metab; 1968 Jul; 28(7):1006-13. PubMed ID: 4298942
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism.
    Magill SB, Raff H, Shaker JL, Brickner RC, Knechtges TE, Kehoe ME, Findling JW.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1066-71. PubMed ID: 11238487
    [Abstract] [Full Text] [Related]

  • 17. Test for pathologic secretion of aldosterone.
    Birchall R, Batson HM.
    JAMA; 1968 Nov 25; 206(9):2114-7. PubMed ID: 5754932
    [No Abstract] [Full Text] [Related]

  • 18. Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites.
    Schirpenbach C, Seiler L, Maser-Gluth C, Rüdiger F, Nickel C, Beuschlein F, Reincke M.
    Eur J Endocrinol; 2006 Jun 25; 154(6):865-73. PubMed ID: 16728547
    [Abstract] [Full Text] [Related]

  • 19. Urine aldosterone radioimmunoassay: validation of a method without chromatography.
    Brown RD, Swander A, McKenzie JK.
    J Clin Endocrinol Metab; 1976 May 25; 42(5):894-900. PubMed ID: 1270582
    [Abstract] [Full Text] [Related]

  • 20. [Diagnosis and lateral localization of primary hyperaldosteronism].
    Vetter W, Siegenthaler W.
    Dtsch Med Wochenschr; 1973 Mar 09; 98(10):506-8. PubMed ID: 4691572
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.